1 - 25 of 183 results for author:"Alitalo K." in Literature citations
Results Customize
› Repeat search in UniProtKB (70)
| Impaired humoral immunity and tolerance in K14-VEGFR-3-Ig mice that lack dermal lymphatic drainage. Thomas S.N., Rutkowski J.M., Pasquier M., Kuan E.L., Alitalo K., Randolph G.J., Swartz M.A. J. Immunol. 189:2181-2190(2012) · Mapped (4) |
| PV-1 is recognized by the PAL-E antibody and forms complexes with NRP-1. Keuschnigg J., Tvorogov D., Elima K., Salmi M., Alitalo K., Salminen T., Jalkanen S. Blood 120:232-235(2012) · Mapped (14) |
| Essential role of the coxsackie- and adenovirus receptor (CAR) in development of the lymphatic system in mice. Mirza M., Pang M.F., Zaini M.A., Haiko P., Tammela T., Alitalo K., Philipson L., Fuxe J., Sollerbrant K. PLoS ONE 7:e37523-e37523(2012) · Mapped (2) |
| Deletion of the endothelial Bmx tyrosine kinase decreases tumor angiogenesis and growth. Holopainen T., Lopez-Alpuche V., Zheng W., Heljasvaara R., Jones D., He Y., Tvorogov D., D'Amico G., Wiener Z., Andersson L.C. et al. Cancer Res. 72:3512-3521(2012) · Mapped (15) |
| In vivo imaging of lymphatic vessels in development, wound healing, inflammation, and tumor metastasis. Martinez-Corral I., Olmeda D., Dieguez-Hurtado R., Tammela T., Alitalo K., Ortega S. Proc. Natl. Acad. Sci. U.S.A. 109:6223-6228(2012) · Mapped (13) |
| Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis. Holopainen T., Saharinen P., D'Amico G., Lampinen A., Eklund L., Sormunen R., Anisimov A., Zarkada G., Lohela M., Helotera H. et al. J. Natl. Cancer Inst. 104:461-475(2012) · Mapped (9) |
| Thermodynamic and structural description of allosterically regulated VEGFR-2 dimerization. Brozzo M.S., Bjelic S., Kisko K., Schleier T., Leppanen V.M., Alitalo K., Winkler F.K., Ballmer-Hofer K. Blood 119:1781-1788(2012) · Mapped (5) |
| KSHV-initiated notch activation leads to membrane-type-1 matrix metalloproteinase-dependent lymphatic endothelial-to-mesenchymal transition. Cheng F., Pekkonen P., Laurinavicius S., Sugiyama N., Henderson S., Gunther T., Rantanen V., Kaivanto E., Aavikko M., Sarek G. et al. Cell Host Microbe 10:577-590(2011) · Mapped (11) |
| Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis. Takeda Y., Costa S., Delamarre E., Roncal C., Leite de Oliveira R., Squadrito M.L., Finisguerra V., Deschoemaeker S., Bruyere F., Wenes M. et al. Nature 479:122-126(2011) · Mapped (2) |
| Expression and prognostic value of transcription factor PROX1 in colorectal cancer. Skog M., Bono P., Lundin M., Lundin J., Louhimo J., Linder N., Petrova T.V., Andersson L.C., Joensuu H., Alitalo K. et al. Br. J. Cancer 105:1346-1351(2011) · Mapped (2) |
| VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling. Tammela T., Zarkada G., Nurmi H., Jakobsson L., Heinolainen K., Tvorogov D., Zheng W., Franco C.A., Murtomaki A., Aranda E. et al. Nat. Cell Biol. 13:1202-1213(2011) · UniProtKB (1) · Mapped (21) |
| VEGF mediates commissural axon chemoattraction through its receptor Flk1. Ruiz de Almodovar C., Fabre P.J., Knevels E., Coulon C., Segura I., Haddick P.C., Aerts L., Delattin N., Strasser G., Oh W.J. et al. Neuron 70:966-978(2011) · Mapped (33) |
| Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse. Kerjaschki D., Bago-Horvath Z., Rudas M., Sexl V., Schneckenleithner C., Wolbank S., Bartel G., Krieger S., Kalt R., Hantusch B. et al. J. Clin. Invest. 121:2000-2012(2011) · Mapped (2) |
| Vascular endothelial growth factor receptor 3 directly regulates murine neurogenesis. Calvo C.F., Fontaine R.H., Soueid J., Tammela T., Makinen T., Alfaro-Cervello C., Bonnaud F., Miguez A., Benhaim L., Xu Y. et al. Genes Dev. 25:831-844(2011) · Mapped (8) |
| Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer. Yang H., Kim C., Kim M.J., Schwendener R.A., Alitalo K., Heston W., Kim I., Kim W.J., Koh G.Y. |
| The tyrosine kinase BMX is an essential mediator of inflammatory arthritis in a kinase-independent manner. Gottar-Guillier M., Dodeller F., Huesken D., Iourgenko V., Mickanin C., Labow M., Gaveriaux S., Kinzel B., Mueller M., Alitalo K. et al. J. Immunol. 186:6014-6023(2011) · Mapped (22) |
| CKIalpha ablation highlights a critical role for p53 in invasiveness control. Elyada E., Pribluda A., Goldstein R.E., Morgenstern Y., Brachya G., Cojocaru G., Snir-Alkalay I., Burstain I., Haffner-Krausz R., Jung S. et al. Nature 470:409-413(2011) · Mapped (18) |
| Roles of prostaglandin E2-EP3/EP4 receptor signaling in the enhancement of lymphangiogenesis during fibroblast growth factor-2-induced granulation formation. Hosono K., Suzuki T., Tamaki H., Sakagami H., Hayashi I., Narumiya S., Alitalo K., Majima M. Arterioscler. Thromb. Vasc. Biol. 31:1049-1058(2011) · Mapped (3) |
| Structural determinants of vascular endothelial growth factor-D - receptor binding and specificity. Leppanen V.M., Jeltsch M., Anisimov A., Tvorogov D., Aho K., Kalkkinen N., Toivanen P., Yla-Herttuala S., Ballmer-Hofer K., Alitalo K. Blood 117:1507-1515(2011) · UniProtKB (1) |
| Suppressive effects of vascular endothelial growth factor-B on tumor growth in a mouse model of pancreatic neuroendocrine tumorigenesis. Albrecht I., Kopfstein L., Strittmatter K., Schomber T., Falkevall A., Hagberg C.E., Lorentz P., Jeltsch M., Alitalo K., Eriksson U. et al. PLoS ONE 5:e14109-e14109(2010) · Mapped (1) |
| Zebrafish Tie-2 shares a redundant role with Tie-1 in heart development and regulates vessel integrity. Gjini E., Hekking L.H., Kuchler A., Saharinen P., Wienholds E., Post J.A., Alitalo K., Schulte-Merker S. Dis Model Mech 4:57-66(2011) · Mapped (6) |
| Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation. Bry M., Kivela R., Holopainen T., Anisimov A., Tammela T., Soronen J., Silvola J., Saraste A., Jeltsch M., Korpisalo P. et al. Circulation 122:1725-1733(2010) · Mapped (1) |
| Fibroblast growth factor receptor 4 regulates tumor invasion by coupling fibroblast growth factor signaling to extracellular matrix degradation. Sugiyama N., Varjosalo M., Meller P., Lohi J., Hyytiainen M., Kilpinen S., Kallioniemi O., Ingvarsen S., Engelholm L.H., Taipale J. et al. Cancer Res. 70:7851-7861(2010) · UniProtKB (1) · Mapped (10) |
| Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation. Huggenberger R., Ullmann S., Proulx S.T., Pytowski B., Alitalo K., Detmar M. J. Exp. Med. 207:2255-2269(2010) · Mapped (3) |
| FGF receptor-4 (FGFR4) polymorphism acts as an activity switch of a membrane type 1 matrix metalloproteinase-FGFR4 complex. Sugiyama N., Varjosalo M., Meller P., Lohi J., Chan K.M., Zhou Z., Alitalo K., Taipale J., Keski-Oja J., Lehti K. Proc. Natl. Acad. Sci. U.S.A. 107:15786-15791(2010) · UniProtKB (1) · Mapped (10) |